Intricon Names Tim Deraney VP of Global Operations

Medtronic leader brings two decades of experience to deliver Intricon services in biosensors, EM navigation, and hearing health

Intricon, developer and manufacturer of medical devices powered by smart miniaturized electronics, has named Tim Deraney as vice president of global operations. Deraney replaces Dennis Gonsior, who retired from Intricon after 41 years with the company.

To Intricon, Tim Deraney brings deep expertise in contract manufacturing in global, multi-site management; change management; and supply chain, logistics and planning leadership. He is certified in Lean, Six Sigma, and specializes in innovating processes, structures, and employee engagement.

Deraney joins Intricon from Medtronic, where he held various leadership positions for 22 years in engineering, manufacturing, and process development, most recently as senior director of global contract manufacturing and OEM contract management.

“Tim’s leadership will be instrumental in meeting the dynamic and complex needs of customers in biosensors, electromagnetic sensors and navigation, and hearing health,” said Scott Longval, president and chief executive officer of Intricon. “He will orchestrate operations across our global footprint.”

Headquartered in Minnesota, the global epicenter of health innovation and care, Intricon has facilities in the U.S. and Asia Pacific, with nearly 250,000 square feet of manufacturing space, 1,000 employees globally, and produces more than 150 million device components and assemblies each year. It is recognized as a top supplier by two of the world’s 10 largest medical device companies.

SourceIntricon

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.